Clinical Pharmacology Study of TS-071 in Paediatric Patients with Type 2 Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-jRCT2080223964
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Type 2 diabetes mellitus
- HbA1c 6.5% to 10.5%
etc.
Exclusion Criteria
- Diabetes mellitus other than type 2
- Fasting plasma glucose exceeding 250 mg/dL at the screening test
- Concurrent urinary tract infection or genital infection, or a history of repeated occurrences of such infection
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>pharmacokinetics<br>pharmacodynamics<br>Pharmacokinetics, pharmacodynamics, and safety
- Secondary Outcome Measures
Name Time Method other<br>-